logo-loader
ASX:AGH

Althea Group Holdings Ltd

Receive alerts
Market:
ASX
Market Cap:
$175.99 m
Price
$0.76
Change
-2.58%
52 weeks high
1.45
52 weeks low
0.18

Filter by article type

Viewing results 1-6 of 6

Industry & services

CB2 Insights strengthens presence in UK medical cannabis market with MyAccess Clinics tie-up

MyAccess Clinics operates multiple clinics in the UK and is focused on providing care for patients with unmet needs...

1 day, 23 hours ago
Tech

CB2 Insights expands data analytics platform to the UK through new medical cannabis pilot program

Project TWENTY21 is a new project to assess the efficacy, safety, quality of life and health outcomes for 20,000 patients using cannabinoid therapies in the UK...

on 19/7/19
Health

Althea Group achieves 1,000-patient milestone for medicinal cannabis prescription

1,000 patients have now been prescribed Althea medicinal cannabis products in Australia....

on 14/6/19
Health

Althea enters UK medicinal cannabis market through acquisition

The company expects to supply medicinal cannabis to patients from around March 2019. ...

on 7/2/19
Health

Althea granted cannabis manufacture licence by Australian Government

The company is working to raise awareness of its products among mainstream doctors and aims to reach 1,000 patients by this time next year....

on 2/11/18
Health

Althea reaches 100 patients for medicinal cannabis products in five months

The company listed on the ASX last month and its shares increased 180% on its first trading day....

on 18/10/18